ACIU - AC Immune SA Operating income before deduction of amortization
Strict FDA oversight and massive R&D expenditures create high barriers to entry. EBITDA analytics on GURU.Markets reflect profit dynamics, where 0.00 determines the current status of the parameter. Unique antibodies guarantee AC Immune patent protection, while the trust of the scientific community and partnerships with industry behemoths strengthen the issuer's reputation in the neuromedicine segment.
Summary analytical data breakdowns for AC Immune SA (ACIU)
- stock quotes and analyst forecast:
- market capitalization statistics:
- balance sheet equity data:
- debt level and financial liquidity data:
- earnings and multiples data:
ACIU - Net Profit|Company Profit Forecast AC Immune|ACIU - Price to Earnings Ratio|Forward P/E Multiple acimmune.com|ACIU - Price/Earnings to Growth Ratio|Enterprise Value to Operating Income Before Depreciation AC Immune|ACIU - Operating profit EBITDA|Net earnings per one share for the last twelve months AC Immune|ACIU - Net earnings per share for the last 12 months|Quarterly EPS earnings growth acimmune.com|ACIU - Earnings per share growth in current year|Expected earnings per share trend next year AC Immune
Summary company analytics:AC Immune
This metric captures the actual volume of cash generated by operating activities before interest and taxes, allowing for an assessment of the business's internal solvency. By analyzing the EBITDA figure, an investor determines the ability of AC Immune (ACIU) to independently fund costly research into neurodegenerative diseases without relying on external loans amidst fierce competition with pharmaceutical behemoths.
Who AC Immune competes with
Income before deduction of interest, taxes and amortization BIIB|Neurocrine Biosciences - Operating profit EBITDA|Operating income before deduction of amortization regencellbioscience.com RGC|Axsome Therapeutics, Inc. (AXSM) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization ACADIA Pharma|Profit before payment of interest, taxes and amortization Xenon Pharmaceuticals Inc|Operating profit before deduction of amortization Viking Therapeutics Corp (VKTX)|Operating profit before deduction of amortization SUPN (Supernus Pharmaceuticals)|Operating profit EBITDA catalystpharma.com (CPRX)|Profit before payment of interest, taxes and amortization Denali Therapeutics Inc. DNLI|HRMY: Operating profit before amortization|Biohaven Pharmaceutical - Operating profit EBITDA|Profit before interest, taxes and amortization Amylyx Corp|TRVI: Operating profit EBITDA|praxismedicines.com (PRAX) - Operating profit EBITDA|AVXL (Anavex Life Sciences Corp.) - Operating profit EBITDA|Operating profit before deduction of amortization CeriBell Inc (CBLL)|Operating profit EBITDA PRTA|Operating income before deduction of amortization alector.com|Annexon, Inc. - Operating profit before deduction of amortization|Operating profit EBITDA Omeros Corp OMER|NGNE - Profit before payment of interest, taxes and amortization|VYGR (Voyager Therapeutics Inc) - Operating profit before amortization|NMRA: Operating profit EBITDA|Profit before interest, taxes and amortization Scilex Holding Company, Inc. (SCLX)|Operating profit before deduction of amortization TVGN|Operating profit EBITDA Alpha Cognition Corp|Profit before payment of interest, taxes and amortization Cognition Therapeutics, Inc. (CGTX)|IKT (Inhibikase Therapeutics Inc) - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Cassava SAVA|Assertio Holdings (ASRT) - Profit before interest, taxes and amortization|Coya - Operating profit EBITDA|VTGN - Operating profit EBITDA|OVID: Operating profit EBITDA|Operating profit before deduction of amortization Acumen Pharmaceuticals Inc.|Operating profit before deduction of amortization CRVO|ATHE: Income before deduction of interest, taxes and amortization|Operating profit EBITDA CLNN|Operating income before deduction of amortization pepgen.com|Profit before payment of interest, taxes and amortization Jupiter Neurosciences JUNS|RLMD - Operating profit before deduction of amortization|ANVS - Profit before payment of interest, taxes and amortization|Grace Therapeutics, Inc. (GRCE) - Operating profit before deduction of amortization|AIFF (Firefly Neuroscience, Inc) - Operating profit before deduction of amortization|Klotho Neurosciences (KLTO) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization NeuroSense Therapeutics Ltd|Operating profit before amortization RVPH (Reviva Pharmaceuticals Holdings Inc.)|Operating profit EBITDA MTVA|NRXS - Profit before interest, taxes and amortization|Operating profit EBITDA HSDT (Helius Medical Technologies)|Operating profit EBITDA Passage Bio Inc. PASG|Neuphoria - Operating profit EBITDA|Minerva Neurosciences Inc (NERV) - Operating profit before deduction of amortization|ATHA: Operating profit EBITDA|ADXN - Operating income before deduction of amortization|Operating profit before deduction of amortization ALZN|Operating profit EBITDA Cyclerion|Profit before payment of interest, taxes and amortization Protagenic Therapeutics (PTIX)|pasitheaclinics.com - Operating profit before amortization|Operating profit EBITDA CRGT (Cortigent)|Avenue Therapeutics Inc (ATXI) - Profit before interest, taxes and amortization|BCLI: Operating profit before deduction of amortization|CARA - Operating profit EBITDA|Chromocell Therapeutics Corp. (CHRO) - Profit before payment of interest, taxes and amortization|Eliem Therapeutics Inc. - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Intra-Cellular Therapies Inc.|Profit before interest, taxes and amortization Longboard LBPH|Operating profit EBITDA MRNS|Operating profit EBITDA nkgenbiotech.com (NKGN)|Operating profit EBITDA NRBO (NeuroBo Pharmaceuticals, Inc.)|SAGE - Operating profit before deduction of amortization|SNPX: Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization TRVN (Trevena Inc)|VIGL: Operating profit EBITDA|WENA - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Cerevel Therapeutics, Inc.
